ArticleSurgical endoscopy2026
Sequential endoscopic and laparoscopic treatment for choledocholithiasis: a 30-year experience in the era of evolving techniques.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSequential endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy (EST) followed by laparoscopic cholecystectomy (LC) is a standard minimally invasive approach for treating concomitant gallbladder and common bile duct stones. This study presents a 30-year experience with this strategy and compares its outcomes with emerging single-session techniques, including laparoscopic common bile duct exploration (LCBDE) and laparoendoscopic rendezvous (LERV).
methodsBetween October 1991 and December 2020, a total of 350 patients (mean age 65 years, range 35-80) underwent EST and/or ERCP followed by LC in a sequential treatment protocol for choledocholithiasis. Patient demographics, intra- and post-procedural variables, complication rates, and long-term outcomes were retrospectively reviewed. The success rate of stone clearance, morbidity, mortality, and recurrence rates were calculated.
resultsOf the 350 treated patients, 240 (68.6%) had confirmed CBD stones. ERCP/EST achieved stone clearance in a single-session in 180 patients (75%). Among the remaining cases, additional ERCP sessions were required, and 14 patients ultimately failed to achieve endoscopic clearance. Three patients discontinued treatment (two declined a second ERCP and one refused LC after endoscopic clearance). Laparoscopic cholecystectomy was aborted in three patients (one due to anesthetic intolerance and two due to severe inflammation). Post-procedural complications occurred in 21 patients (6%), predominantly comprising mild pancreatitis and minor bile leak, or wound infections. No mortality was observed. Median hospital stay was 5.5 days. Recurrent CBD stones were observed in 15 patients (4.3%), managed with repeat ERCP (8 cases) or surgical revision (7 cases).
conclusionsWhile sequential therapy remains an effective and widely adopted technique, the growing body of evidence on single-session, minimally invasive strategies such as LCBDE and LERV offers valuable alternatives in selected scenarios. Each approach presents specific advantages and challenges, and the choice of treatment should be guided by individual patient characteristics, clinical context and available institutional expertise.
Indexed as
Identifiers
41136653What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.